- Molecular Genetics of Cancer – Nikhil Wagle, MD
- Advances in Cancer Drug Development Part I – Chemotherapy and Targeted Agents – Geoffrey I. Shapiro, MD, PhD
- Advances in Cancer Drug Development Part II – Modulation of the Tumor Microenvironment – Geoffrey I. Shapiro, MD, PhD
- Infections in Cancer Patients – Lindsey Baden, MD
- Symptom Management in Patients with Cancer – Andrew J. Lawton, MD
- Communication: The Key to Excellence in End-of-Life Care – Rachelle E. Bernacki, MD
- Biology of Hematopoietic Stem Cell Transplantation – Robert J. Soiffer, MD
- Biology of Acute Leukemia and Myelodysplastic Syndromes – Benjamin L. Ebert, MD, PhD
- Acute Leukemias – Daniel J. DeAngelo, MD, PhD
- Myelodysplastic Syndrome – Eric S. Winer, MD
- Chronic Myelogenous Leukemia – Marlise R. Luskin, MD
- Myeloproliferative Syndromes – Ann M. Mullally, MD
- Multiple Myeloma – Kenneth C. Anderson, MD
- Waldenstrom Macroglobulemia and Amyloidosis – Jorge Castillo, MD
- Low Grade Lymphomas – Caron A. Jacobson, MD
- Aggressive Non-Hodgkin Lymphoma – Eric Jacobsen, MD
- Hodgkin’s Lymphoma – Reid W. Merryman, MD
- Diagnosis and Treatment of CLL and Related B Cell Malignancies – Matthew S. Davids, MD
- Head and Neck Cancer – Robert I. Haddad, MD
- Natural History, Screening, and Small Cell Lung Cancer – Bruce E. Johnson, MD
- Non Small Cell Lung Cancer – Part 1 – Mark Awad, MD, PhD
- Non Small Cell Lung Cancer – Part 2 – Mark Awad, MD, PhD
- Mesothelioma and Thymoma – David M. Jackman, MD
- Carcinoid and Neuroendocrine Tumors – Jennifer Ang Chan, MD
- Novel Approaches for the Management of Esophageal and Gastric Cancers – Peter C. Enzinger, MD
- Pancreatic Cancer – Brian M. Wolpin, MD
- Hepatobiliary Cancer – James M. Cleary, MD, PhD
- Anal Cancer & Colorectal Cancers Part 1 – Robert J. Mayer, MD
- Colorectal Cancers Part 2 – Robert J. Mayer, MD
- Gastrointestinal Cancer: Genetic Syndromes – Matthew Yurgelun, MD
- Testicular Cancer – Mark M. Pomerantz, MD
- Renal and Bladder Cancer – Guru P. Sonpavde, MBBS
- Prostate Cancer Part I: Overview and Management of Localized Disease – Atish Choudhury, MD, PhD
- Prostate Cancer Part II: Management of Disseminated Prostate Cancer – Atish Choudhury, MD, PhD
- Melanoma – F. Stephen Hodi, MD
- Sarcomas and Gastrointestinal Stromal Tumors (GIST) – Suzanne George, MD
- Molecular Advances and Emerging Treatment Strategies in Ovarian Cancer – Ursula A. Matulonis, MD
- Cervical and Endometrial Cancer – Panagiotis A. Konstantinopoulos, MD, PhD
- Neuro-oncology – David A. Reardon, MD
- Breast Cancer – Risk Factors, Genetics, Screening, and Prevention – Judy E. Garber, MD, MPH
- Multimodality Therapy for Early Stage Breast Cancer: Part 1 – Surgery and Radiation – Harold J. Burstein, MD, PhD
- Multimodality Therapy for Early Stage Breast Cancer: Part 2 – Systemic Therapy – Harold J. Burstein, MD, PhD
- Management of Metastatic Breast Cancer – Adrienne G. Waks, MD
- Breast Cancer Survivorship – Ann H. Partridge, MD, MPH
- Hematopoiesis and Cytokines – David T. Scadden, MD
- Acquired Bone Marrow Failure – Julie-Aurore Losman, MD, PhD
- Congenital Bone Marrow Failure – Akiko Shimamura, MD, PhD
- Hemophagocytic Syndromes and Related Immunodeficiencies – Barbara A. Degar, MD
- Anemia – An Overview – Robert Stern, MD
- Iron Deficiency and Iron Overload – Mark D. Fleming, MD, Dphil
- Immune Hemolytic Anemia – Richard M. Kaufman, MD
- Non-immune Hemolytic Anemia – David E. Golan, PhD, MD
- Sickle Cell Disease – Maureen M. Achebe, MD, MPH
- Thalassemia and Other Hemoglobinopathies – Matthew M. Heeney, MD
- Disorders of Neutrophils – Nancy Berliner, MD
- Acquired Thrombocytopenias – Elisabeth M. Battinelli, MD, PhD
- Hemophilia – Aric D. Parnes, MD
- Von Willebrand Disease and Congenital Platelet Disorders – Nathan T. Connell, MD, MPH
- Congenital and Acquired Thrombophilia – Kenneth A. Bauer, MD
- Use of Direct Oral Anticoagulants in Clinical Practice – Jean M. Connors, MD
- Transfusion Medicine for the Clinician – Walter H. Dzik, MD
The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology 2022
The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology 2022
Regular price
$50.00 USD
Regular price
$50.00 USD
Sale price
Unit price
per
Couldn't load pickup availability
The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology 2022
Regular price
$50.00
Regular price
$50.00
Sale price
Unit price
per
The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology 2022
Topics/Speakers
